UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Suicide-related behaviours in schizophrenia in China: A comprehensive meta-analysis Journal article
Dong,M., Wang,S. B., Wang,F., Zhang,L., Ungvari,G. S., Ng,C. H., Meng,X., Yuan,Z., Wang,G., Xiang,Y. T.. Suicide-related behaviours in schizophrenia in China: A comprehensive meta-analysis[J]. Epidemiology and Psychiatric Sciences, 2019, 28(3), 290-299.
Authors:  Dong,M.;  Wang,S. B.;  Wang,F.;  Zhang,L.;  Ungvari,G. S.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:18  IF:5.9/7.3 | Submit date:2021/03/02
China  Meta-analysis  Schizophrenia  Suicide  
Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies Journal article
F. Wang, S. Wang, Q.-Q. Zong, Q. Zhang, C.H.Ng, G. S. Ungvari, Y.-T. Xiang. Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies[J]. DIABETIC MEDICINE, 2019, 36(8), 961-969.
Authors:  F. Wang;  S. Wang;  Q.-Q. Zong;  Q. Zhang;  C.H.Ng; et al.
Favorite | TC[WOS]:57 TC[Scopus]:59  IF:3.2/4.0 | Submit date:2021/03/02
Relationship of sleep duration with demographics, lifestyle, mental health, and chronic diseases Conference paper
Ng, C. H., Wang, S. B., Li, B., Wu, Y. H., Ungvari, G. S., Fu, Y. L., Kou, C. G., Yu, Y. Q., Sun, H. Q., Xiang, Y. T.. Relationship of sleep duration with demographics, lifestyle, mental health, and chronic diseases[C], THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND:PERGAMON-ELSEVIER SCIENCE LTD, 2018, 122-122.
Authors:  Ng, C. H.;  Wang, S. B.;  Li, B.;  Wu, Y. H.;  Ungvari, G. S.; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date:2018/10/30
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials Journal article
Zheng, W., Zhang, Q. -E., Cai, D. -B., Yang, X. -H., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y. -P., Xiang, Y. -T.. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2018, 137(5), 391-400.
Authors:  Zheng, W.;  Zhang, Q. -E.;  Cai, D. -B.;  Yang, X. -H.;  Qiu, Y.; et al.
Favorite | TC[WOS]:65 TC[Scopus]:67  IF:5.3/6.6 | Submit date:2018/10/30
N-acetylcysteine  Oxidative Stress  Schizophrenia  Bipolar Disorder  Major Depressive Disorder  
Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia Journal article
Y.-T. Xiang, G. S. Ungvari, C. U. Correll, H. F. K. Chiu, N. Shinfuku. Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia[J]. Epidemiology and Psychiatric Sciences, 2016, 25(1), 9-17.
Authors:  Y.-T. Xiang;  G. S. Ungvari;  C. U. Correll;  H. F. K. Chiu;  N. Shinfuku
Favorite | TC[WOS]:18 TC[Scopus]:18  IF:5.9/7.3 | Submit date:2019/01/07
Asia  Schizophrenia  Prescription Patterns  Psychotropic Medications  
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.; et al.
Favorite | TC[WOS]:109 TC[Scopus]:117 | Submit date:2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability